Ectodysplasin A is associated with the presence and severity of coronary artery disease and poor long-term clinical outcome in patients presenting with ST-elevation myocardial infarction

References

• Esfahani M, Baranchi M, Goodarzi MT. The implication of hepatokines in metabolic syndrome. Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2477–2480.
   PubMed Web of Science ®Google Scholar
• Jensen-Cody SO, Potthoff MJ. Hepatokines and metabolism: deciphering communication from the liver. Mol Metab. 2021;44:101138.
   PubMed Web of Science ®Google Scholar
• Jung TW, Yoo HJ, Choi KM. Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clin. 2016;5:108–113.
   PubMed Web of Science ®Google Scholar
• Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013;9:144–152.
   PubMed Web of Science ®Google Scholar
• Cai D, Yuan M, Frantz DF, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11:183–190.
   PubMed Web of Science ®Google Scholar
• Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes. 2011 Aug;60(8):2011–2017.
   PubMed Web of Science ®Google Scholar
• Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab. 2010;21(12):707–713.
   PubMed Web of Science ®Google Scholar
• Bayliss J, Ooi GJ, De Nardo W, et al. Ectodysplasin A is increased in non-alcoholic fatty liver disease, but is not associated with type 2 diabetes. Front Endocrinol (Lausanne). 2021 Mar 4;12:642432.
   PubMed Web of Science ®Google Scholar
• Kowalczyk-Quintas C, Schneider P. Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation. Cytokine Growth Factor Rev. 2014 Apr;25(2):195–203.
   PubMed Web of Science ®Google Scholar
• Cai Z, Deng X, Jia J, et al. Ectodysplasin A/ectodysplasin A receptor system and their roles in multiple diseases. Front Physiol. 2021 Dec;6(12):788411.
   Google Scholar
• Deng X, Cai Z, Li Y, et al. Increased circulating levels of ectodysplasin A in newly diagnosed type 2 diabetic patients. Front Endocrinol (Lausanne). 2021 Nov 9;12:737624.
   PubMedGoogle Scholar
• Sadier A, Viriot L, Pantalacci S, et al. The ectodysplasin pathway: from diseases to adaptations. Trends Genet. 2014 Jan;30(1):24–31.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou W, Zhu J, et al. Circulating ectodysplasin A is a potential biomarker for nonalcoholic fatty liver disease. Clin Chim Acta. 2019 Dec;499:134–141.
   PubMed Web of Science ®Google Scholar
• Awazawa M, Gabel P, Tsaousidou E, et al. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle. Nat Med. 2017;23(12):1466–1473.
   PubMed Web of Science ®Google Scholar
• Singh M, Sharma PK, Garg VK, et al. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol. 2012 Dec;64(12):1703–1708.
   PubMed Web of Science ®Google Scholar
• Li Z, He C, Liu Y, et al. Association of fetuin-B with subclinical atherosclerosis in obese Chinese adults. J Atheroscler Thromb. 2020 May 1;27(5):418–428.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang J, Lai J, et al. Circulating retinol binding protein 4 levels in coronary artery disease: a systematic review and meta-analysis. Lipids Health Dis. 2021 Aug 21;20(1):89.
   PubMed Web of Science ®Google Scholar
• Wu L, Qian L, Zhang L, et al. Fibroblast growth factor 21 is related to atherosclerosis independent of nonalcoholic fatty liver disease and predicts atherosclerotic cardiovascular events. J Am Heart Assoc. 2020 Jun 2;9(11):e015226.
   PubMed Web of Science ®Google Scholar
• Schomburg L, Orho-Melander M, Struck J, et al. Selenoprotein-P deficiency predicts cardiovascular disease and death. Nutrients. 2019 Aug 9;11(8):1852.
   PubMed Web of Science ®Google Scholar
• Aryal B, Price NL, Suarez Y, et al. ANGPTL4 in metabolic and cardiovascular disease. Trends Mol Med. 2019 Aug;25(8):723–734.
   PubMed Web of Science ®Google Scholar
• Wei M, Liu J, Pan H, et al. Plasma Leukocyte Cell-Derived Chemotaxin 2 (LECT2) as a risk factor of coronary artery disease: a cross-sectional study. Angiology. 2022 Mar;73(3):265–274.
   PubMed Web of Science ®Google Scholar
• Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019 Aug;234(10):16812–16823.
   PubMed Web of Science ®Google Scholar
• Gaggini M, Morelli M, Buzzigoli E, et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013 May 10;5(5):1544–1560.
   PubMed Web of Science ®Google Scholar
• Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev Esp Enferm Dig. 2015 Jan;107(1):10–16.
   PubMed Web of Science ®Google Scholar
• Bril F, Barb D, Portillo-Sanchez P, et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology. 2017 Apr;65(4):1132–1144.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang S, Lv W, et al. Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis. BMJ Open Diabetes Res Care. 2020 May;8(1):e001217.
   PubMed Web of Science ®Google Scholar
• Formentini FS, Zaina Nagano FE, Lopes Neto FDN, et al. Coronary artery disease and body mass index: what is the relationship? Clin Nutr ESPEN. 2019 Dec;34:87–93.
   PubMed Web of Science ®Google Scholar
• Infante T, Forte E, Aiello M, et al. In vivo and in vitro analysis in coronary artery disease related to type 2 diabetes. Front Endocrinol (Lausanne). 2017 Aug 21;8:209.
   PubMed Web of Science ®Google Scholar
• Jahangir E, De Schutter A, Lavie CJ. The relationship between obesity and coronary artery disease. Transl Res. 2014 Oct;164(4):336–344.
   PubMed Web of Science ®Google Scholar
• Wang B, Liang Y, Chai X, et al. Ectodysplasin A receptor (EDAR) promotes colorectal cancer cell proliferation via regulation of the Wnt/β-catenin signaling pathway. Exp Cell Res. 2020 Oct 1;395(1):112170.
   PubMed Web of Science ®Google Scholar
• Sinha SK, Zachariah S, Quiñones HI, et al. Role of TRAF3 and −6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem. 2002 Nov 22;277(47):44953–44961.
   PubMed Web of Science ®Google Scholar
• Han X, Yoshizaki K, Miyazaki K, et al. The transcription factor NKX2-3 mediates p21 expression and ectodysplasin-A signaling in the enamel knot for cusp formation in tooth development. J Biol Chem. 2018 Sep 21;293(38):14572–14584.
   PubMed Web of Science ®Google Scholar
• Weerackoon N, Gunawardhana KL, Mani A. Wnt signaling cascades and their role in coronary artery health and disease. J Cell Signal. 2021;2(1):52–62.
   PubMedGoogle Scholar
• Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease. World J Gastroenterol. 2011 Sep 7;17(33):3785–3794.
   PubMed Web of Science ®Google Scholar
• Baker AR, Harte AL, Howell N, et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009 Jan;94(1):261–267.
   PubMed Web of Science ®Google Scholar
• Guo F, Tang C, Li Y, et al. The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-κB signalling pathway. J Cell Mol Med. 2018 Oct;22(10):5062–5075.
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Carmody RJ. NF-κB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41–84.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Z, Zhou M, et al. Therapeutic effects of fibroblast growth factor‑21 against atherosclerosis via the NF-κB pathway. Mol Med Rep. 2018 Jan;17(1):1453–1460.
   PubMed Web of Science ®Google Scholar
• Yang CH, Hsieh MJ, Chen CC, et al. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction. Coron Artery Dis. 2012 Nov;23(7):445–449.
   PubMed Web of Science ®Google Scholar